跳至主要内容
临床试验/ACTRN12620000973910
ACTRN12620000973910已完成未知

Effects of saffron on sleep quality in adults with unsatisfactory sleep: a randomised, double-blind, placebo-controlled study

Clinical Research Australia0 个研究点目标入组 120 人开始时间: 2020年9月28日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • 1. Healthy adults (male and female) between 18 and 70
  • 2. Self-reported symptoms of poor sleep lasting longer than 4 weeks
  • 3. Non-smoker
  • 4. BMI between 20 and 35
  • 5. Typical bedtime between 9 p.m. and 12 a.m.
  • 6. Willing to provide a personally-signed and dated informed consent form detailing all pertinent aspects of the trial.

排除标准

  • 1. Employed in night shift work or rotational shift work
  • 2. Suffer from a sleep disorder other than moderate insomnia (e.g, sleep apnoea, restless leg syndrome, periodic limb movement disorder)
  • 3. Suffer from mental health disorder other than mild depressive or anxiety symptoms as measured by the Patient Health Questionnaire (PHQ-4)
  • 4. Coffee intake greater than 3 cups a day (or equivalent caffeine intake from other caffeinated drinks e.g., tea, energy drinks)
  • 5. Alcohol consumption > 14 standard drinks per week
  • 6. Experiencing external factors that may affect sleep patterns (e.g., infant/children regularly wakening, excess noise, a snoring partner, pain condition)
  • 7. Currently receiving non-pharmacological treatment of sleep disorders (e.g., cognitive behavioural therapy, relaxation therapy)
  • 8. Current or 12-month history of illicit drug abuse
  • 9. Pregnant women, women who are breastfeeding, or women who intended to fall pregnant.
  • 10. Suffering from recently diagnosed or unmanaged medical conditions including but not limited to: diabetes, hyper/hypotension, cardiovascular disease, gastrointestinal disease requiring regular use of medications, gallbladder disease/gallstones/biliary disease, autoimmune disease, endocrine disease, acute or chronic pain condition
  • 11. Diagnosis of medical or psychiatric conditions including but not limited to: psychiatric disorder (other than mild-to-moderate depression or anxiety), neurological disease (Parkinson’s, Alzheimer’s disease, intracranial haemorrhage, head or brain injury), and cancer/malignancy
  • 12. Current use of pharmaceutical medications that may affect sleep quality
  • 13. Current use of supplements that may affect sleep
  • 14. Currently taking saffron supplements

研究者

发起方
Clinical Research Australia

相似试验